News in the Life Sciences Industry

LUND, Sweden, July 19, 2018 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, today announced that the company has submitted a clinical trial authorization (CTA)... Read more ››

TOREKOV, Sweden, July 19, 2018 /PRNewswire/ --

HUDDINGE, Sweden, July 19, 2018 /PRNewswire/ -- INTERIM REPORT JANUARY - JUNE 2018

LUND, Sweden, 16 July, 2018 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) announced today that the US Food and Drug Administration (FDA) assigned a Prescription Drug User Fee Act (PDUFA) goal date of December 26, 2018 for its investigational weekly and monthly buprenorphine depots, CAM2038, for... Read more ››

HUDDINGE, Sweden, July 16, 2018 /PRNewswire/ -- During the period 9 July 2018 to 13 July 2018, Karo Pharma AB (publ) (LEI code 213800G54Z51LOPGTA79) has repurchased in total 387,062 own shares (ISIN: SE00007464888). The repurchases form part of the SEK 86.3 million share repurchase programme... Read more ››

UPPSALA, Sweden, July 16, 2018 /PRNewswire/ --

STOCKHOLM, July 13, 2018 /PRNewswire/ -- Envirotainer, the global market leader in temperature controlled airfreight solutions for the pharmaceutical supply chain, today announced that Cinven, the international private equity firm, has signed an agreement to acquire all shares in Envirotainer... Read more ››

STOCKHOLM, July 12, 2018 /PRNewswire/ -- Positive data for our preclinical projects

GÖTEBORG, Sweden, July 11, 2018 /PRNewswire/ -- Capio has signed an agreement to acquire 100% of Legevisitten with specialist care operations, mainly focusing on healthcare for the elderly, and primary care activities. In 2017, the group's net sales were MSEK 613, of which 90% was related... Read more ››

UPPSALA, Sweden, July 11, 2018 /PRNewswire/ -- Q2 2018 highlights

STOCKHOLM, July 11, 2018 /PRNewswire/ -- Cantargia AB announce that the European Patent Office (EPO) has issued an Intention to grant notification for the company's divisional (second, follow-up) patent application regarding use of IL1RAP as a target for antibody therapy in solid tumours.... Read more ››

STOCKHOLM, July 11, 2018 /PRNewswire/ -- GomSpace A/S - a subsidiary of GomSpace Group AB (the "Company") has signed a 400.000 EUR contract with ESA for the first phase of the RACE project to deliver two 6-unit CubeSats for an IOD mission to demonstrate the capability of nano-satellite systems... Read more ››

STOCKHOLM, July 10, 2018 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company has received approval by Fimea, the Finnish Medicines Agency, and Valvira, the Finnish authority for medical device, as well as the local ethics committee for inclusion of... Read more ››